Anti-epileptics Flashcards

1
Q

Which 2 drugs are selective fast-acting Na channel blockers?

A

Phenytoin, Carbamazepine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which 3 drugs are fast-acting Na channel blockers with additional MOA?

A

Lamotrigine, Topiramate, Valproic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which drug is a T type Ca channel blocker?

A

Ethosuximide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which drug is a presynptic alpha2-delta subunit Ca channel modulator?

A

Gabapentin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which drug is a synaptic transmission modulator?

A

Levetiracetam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which drug can be used to treat gen status epilepticus?

A

Phenytoin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which two drugs can be used to treat gen absence?

A

valproic acid, ethosuximide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which type of seizure is not sensitive to Na channel blockers?

A

absence (too slow)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What event triggers seizures and how? How do AED’s work against this mechanism?

A
  • Paroxysmal depolarizing shift: long lasting local depolarization that moves neuron close to threshold for Na channel activation
  • the fast Na dependent AP’s sitting on top of PDS can propagate to other regions of the brain —- AED’s prevent spread in this manner, but do not act against the trigger PDS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which drug is preferred in treating TC seizures, and essential for SE treatment after acute phase?

A

Phenytoin (good for SE because it’s injectable)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the main pathway for metabolism of phenytoin?

A

CYP2C9 oxidation – glucoronic conjugation = hepatic metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Unique pharmacokinetics of phenytoin?

A
  • Non-linear because therapeutic concentrations exceed drug’s Km
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are 2 ways phenytoin can affect metabolism of other drugs?

A
  • CYP2C9 inducer

- extensively bound to plasma proteins (valproic acid)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Advantages of phenytoin prodrug Fosphenytoin?

A
  • more water soluble
  • better tolerated (injection suspension of phenytoin is basic and irritating)
  • rapidly converted to phenytoin in blood
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What 3 drug classes are associated with gingival overgrowth? Why?

A
  • phenytoin > cyclosporine (immuneodepressant) > nifedipine (Ca channel blocker)
  • increase secretion/effect of inflammatory cytokines –> increase in fibroblast secreted ECM in gingiva
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Along with sulfa AB’s, what drug is commonly associated with Stevens’Johnson syndrome?

A

Phenytoin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are 4 severe and 3 common AE’s associated with phenytoin?

A
  • Cardiac arrhythmias/inhibition
  • hypersensitivity (genetics, Asian)
  • teratogenic to fetal heart
  • decreased bone mineral density
  • Lethargy, CNS depression, ataxia, nystagmus – DOSE DEPENDENT
18
Q

3 uses of carbamazepine? Why not SE?

A
  • long term TC treatment
  • bipolar, neuropathic pain
  • not available as injectable
  • CAN AGGRAVATE ABSENCE
19
Q

Metabolism and potentiation drug interactions of carbamazepine? Unique qualities of metabolism?

A
  • metab by multiple CYP450 (3A4)
  • induces CYP2C19 and 3A4
  • first order kinetics, AUTOINDUCTION (must titrate over time)
20
Q

Which AED is most clearly associated with decreased bone mineral density? MOA?

A
  • Carbamazepine (also phenytoin)
  • secondary hyperparathyroidism due to induction of CYP24 that inactivates calcotriol (low calcitriol, low serum Ca levels, parathyroid mobilized in response to release Ca from bones)
21
Q

Two black box warnings associated with Carbamazepine?

A
  • hypersensitivity (toxic epidermal necrolysis, Stevens Johnson)
  • agranulocytosis/aplastic anemia (rare, but pot. fatal)
22
Q

MOA and uses of Lamotrigine?

A
  • fast Na channel blocker, weak Ca blocker

- adjunct in TC Tx (alternative for absence due to Ca effects)

23
Q

Metabolism of lamotrigine? Drug interactions?

A
  • CYP450
  • Phenytoin, carbamazepine induce elimination
  • valproic acid inhibits elimination
24
Q

Black box warning and other AE’s associated with Lamotrigine? Black box target population?

A
  • hypersensitivity (most common in children)
  • aseptic meningitis due to rare drug irritation
  • teratogen – BUT LOWER risk than other Na blockers
  • CNS effects (no sig sedation)
25
MOA and uses of valproic acid?
- fast Na blocker, weak Ca blocker (VERY weak enhancement of GABA transmission) - BROADEST RANGE - absence - most useful for complicated epilepsy syndromes w/ multiple seizure types - migraine prophylaxis - bipolar
26
Double anti-epileptic mechanism of valproic acid?
- decreases neuronal hypersensitivity primarily by inhibiting neuronal excitation (like others) - GABA enhanced transmission makes minor contribution by enhancing neuronal inhibition
27
Elimination mechanisms for valproic acid?
- hepatic conjugation AND oxidation - conjugation is most important - VPA can also be burned via mito/ER oxidation
28
Two drug interactions associated with valproic acid?
- phenytoin/carbamazepine induce hepatic glucoronyltransferase - BOTH phenytoin and VPA are extensively bound to plasma proteins ---- competition can lead to increased blood levels of free phenytoin (non-linear pharmacokinetics)
29
Two black box warnings associated with VPA?
- teratogenicity (HIGH NTD's, cognitive) | - hepatotox/pancreatitis (more common in children)
30
Topiramate MOA and uses?
- fast Na blocker with supplemental mech (poorly understood, complex: augment activation of GABAa receptors, antagonize glut kainate receptors-- also carbonic anhydrase inhibition = metab acidosis) - BROAD: TC, partial (focal), migraines
31
4 AE's associated with topiramate?
- CNS sedation, cog effects (more common in adults) - metab acidosis (renal carbonic anhydrase inhibition) - teratogenicity (cleft lip, palate) - weigh loss
32
How does renal carbonic anhydrase inhibition associated with topiramate cause metab acidosis?
- CA inhibition decreases renal bicarb reabsorption | - loss of bicard can induce metab acidosis
33
Elimination and drug interactions of Topiramate?
- renal - hyperammonemia with VPA - other CA inhibitors = metab acidosis
34
MOA and use of Ethosuximide?
- T type Ca blocker | - ONLY absence
35
Cellular targets of ethosuximide?
- T-type Ca channels on thalamic relay neurons that regularly produce PDS - absence seizures generated by thalamocortical and corticothalamic excitatory pathways that cyclically stimulate each other and cause 3Hz spike and wave EEG absence pattern
36
Metabolism of ethosuximide?
- mostly CYP3A4 (but no induction issues) | - some renal
37
3 AE's associated with ethosuximide?
- GI distress = common - bone marrow depression - hypersensitivity
38
MOA and uses of gabapentin?
- presynaptic alpha-2 delta Ca channel modulator (binds alpha2delta subunits and prevents incorporation into P/Q type Ca channels which are found in pre-syn nerve terminals and are closely linked to exocytosis and neurotransmission) - adjunct for refractory partial seizures - neuropathic pain
39
Elimination and absorption of gabapentin?
- RENAL (fewer interactions bc not hepatic) | - oral bioavailability limited at HIGH doses due to SATURATION of GI uptake transporters (spread doses throughout day)
40
MOA and uses of Levetiracetam?
- synaptic transmission modulator (binds to synaptic vesicle protein 2 and DECREASES synaptic vesicle release for a variety of NT's) - partial or generalized seizures - adjunct to other AED's
41
Elimination of levetiracetam?
RENAL (no interactions)
42
AE's associated with levetiracetam?
- reversible, less severe - weakness, fatigue, asthenia - BEHAVIORAL problems